EUVIMEDEUVIMED entdecken
Crossref

Ythdf1 deficiency exacerbates colitis but prevents colitis-associated cancer in mice

Zhen Zhang, Jie Zhang, Chenzhong Xu, Yuping Ning, Baohua Liu

Ageing and Cancer Research & Treatment · 2024

DOI: 10.70401/acrt.2026.0009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ageing and Cancer Research & Treatment, 2024. Verfasst von Zhen Zhang und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Recurrent and uncontrolled inflammation of the colon may cause inflammatory bowel diseases (IBD), which are strongly associated with the onset of colitis-associated cancer (CAC). However, the molecular mechanisms linking inflammation, dysregulated growth, and tumorigenesis remain unclear. This study aims to determine the role of the N6-methyladenosine (m6A) reader YTH m6A RNA binding protein 1 (Ythdf1) in regulating colitis severity and CAC development.

Methods

Ythdf1-deficient and wild-type mice were subjected to dextran sodium sulfate (DSS)-induced colitis to evaluate disease severity, epithelial survival, goblet cell and mucus preservation, and inflammatory signaling. m6A-dependent regulation of Jak1 mRNA and the Il6-Jak1-Stat3 pathway activation was assessed through molecular analyses. Additionally, an azoxymethane (AOM)/DSS model was used to determine the impact of Ythdf1 loss on CAC development.

Results

Ythdf1 deficiency significantly worsened DSS-induced colitis, with increased epithelial damage, loss of goblet cells and mucus, impaired epithelial survival, and reduced Stat3 activation. Mechanistically, Ythdf1 recognized m6A-modified Jak1 mRNA and enhanced Jak1 protein expression, thereby maintaining the Il6-Jak1-Stat3 signaling during inflammatory stress. Despite aggravating colitis, Ythdf1 loss markedly suppressed CAC progression and reduced tumor burden.

Conclusion

Ythdf1 is a key regulator of intestinal homeostasis, maintaining the Il6-Jak1-Stat3 signaling to protect against colitis while paradoxically promoting CAC progression. These findings identify Ythdf1 as a context-dependent modulator of intestinal inflammation and tumorigenesis, highlighting its therapeutic potential in IBD and CAC.

Zitieren

APA

Zhang, Z., Zhang, J., Xu, C., Ning, Y., & Liu, B. (2024). Ythdf1 deficiency exacerbates colitis but prevents colitis-associated cancer in mice. Ageing and Cancer Research & Treatment. https://doi.org/10.70401/acrt.2026.0009

Vancouver

Zhang Z, Zhang J, Xu C, Ning Y, Liu B. Ythdf1 deficiency exacerbates colitis but prevents colitis-associated cancer in mice. Ageing and Cancer Research & Treatment. 2024. doi:10.70401/acrt.2026.0009

BibTeX
@article{Zhang2024,
  author = {Zhang, Zhen and Zhang, Jie and Xu, Chenzhong and Ning, Yuping and Liu, Baohua},
  title = {Ythdf1 deficiency exacerbates colitis but prevents colitis-associated cancer in mice},
  journal = {Ageing and Cancer Research & Treatment},
  year = {2024},
  doi = {10.70401/acrt.2026.0009}
}
Kostenlos starten →